Area of research
Pulmonary and Respiratory Medicine · Epidemiology
Research interest
Research interests include Medicine, Inflammatory bowel disease, Interstitial lung disease, Pediatrics, Disease, and Single-nucleotide polymorphism.
Phase-resolved Functional Lung MRI Reveals Distinct Lung Perfusion Phenotype in Children and Adolescents with Post–COVID-19 Condition
RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021–2023
Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype–phenotype correlations
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
ABCA3-related interstitial lung disease beyond infancy
Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019–2022
Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease
The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN
Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases
Comparison of the Lung Clearance Index in Preschool Children With Primary Ciliary Dyskinesia and Cystic Fibrosis
Heterogenous Disease Course and Long-Term Outcome of Children’s Interstitial Lung Disease Related to Filamin A Gene Variants
Interventional Bronchus Occlusion Using Amplatzer Devices – A Promising Treatment Option for Children with Persistent Air Leak
COVID-19 related reduction in pediatric emergency healthcare utilization – a concerning trend
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry
Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial
Pulmonary interstitial glycogenosis – A systematic analysis of new cases
International management platform for children’s interstitial lung disease (chILD-EU)
European protocols for the diagnosis and initial treatment of interstitial lung disease in children
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status
Persistent Tachypnea of Infancy. Usual and Aberrant
Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
Gene Correction of Human Induced Pluripotent Stem Cells Repairs the Cellular Phenotype in Pulmonary Alveolar Proteinosis
IRGM Variants and Susceptibility to Inflammatory Bowel Disease in the German Population
PTPN2 Gene Variants Are Associated with Susceptibility to Both Crohn's Disease and Ulcerative Colitis Supporting a Common Genetic Disease Background
Analysis of IL12B Gene Variants in Inflammatory Bowel Disease
PTGER4 Expression-Modulating Polymorphisms in the 5p13.1 Region Predispose to Crohn's Disease and Affect NF-κB and XBP1 Binding Sites